Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-16-000678
Filing Date
2016-05-13
Accepted
2016-05-13 12:20:49
Documents
55
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q irsb0511form10q.htm 10-Q 277178
2 EXHIBIT 31.1 irsb0511form10qexh31_1.htm EX-31.1 10284
3 EXHIBIT 32.1 irsb0511form10qexh32_1.htm EX-32.1 4700
  Complete submission text file 0001554795-16-000678.txt   2273944

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE irsb-20160331.xml EX-101.INS 360812
5 XBRL SCHEMA FILE irsb-20160331.xsd EX-101.SCH 29710
6 XBRL CALCULATION FILE irsb-20160331_cal.xml EX-101.CAL 37396
7 XBRL DEFINITION FILE irsb-20160331_def.xml EX-101.DEF 126840
8 XBRL LABEL FILE irsb-20160331_lab.xml EX-101.LAB 213789
9 XBRL PRESENTATION FILE irsb-20160331_pre.xml EX-101.PRE 196176
Mailing Address 5201 GREAT AMERICA PARKWAY SUITE 320 SANTA CLARA CA 95054
Business Address 5201 GREAT AMERICA PARKWAY SUITE 320 SANTA CLARA CA 95054 408-867-2885
IRIS BIOTECHNOLOGIES INC (Filer) CIK: 0001396238 (see all company filings)

EIN.: 770506396 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53245 | Film No.: 161646996
SIC: 3841 Surgical & Medical Instruments & Apparatus